iRhythm Holdings, Inc. IRTC 深 沪
已收盘 02-06 16:00:00 美东时间
146.47
-0.280
-0.19%
华盛通- 最 高150.31
- 今 开148.50
- 成交量 89.34万股
- 最 低 146.10
- 昨 收 146.75
- 总市值 47.19亿
- 52周最高 212.00
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 92.52
- 委 比 -47.23%
- 总股本 3221.91万
- 历史最高 286.19
- 量 比 1.12
- 振 幅 2.87%
- 历史最低 22.25
- 每 手 1
- 风险率 28.49%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多iRhythm Tech's Stock Selloff Went Too Far After Preliminary Update: Analyst
iRhythm shares slid after a Zio MCT delay, but William Blair says the selloff is overdone and keeps an Outperform rating, citing growth potential and attractive valuation.
01-15 01:43
美股大行评级 | 高盛上调谷歌目标价从330美元升至375美元；5家大行集体上调Five Below目标价最高至255美元
今日重点评级关注：HC Wainwright & Co.：维持NioCorp Developments"买入"评级，目标价从9.5美元升至11.25美元；摩根士丹利：维持Chewy"超配"评级，目标价从48美元升至51美元
01-14 11:25
Wells Fargo Maintains Overweight on iRhythm Technologies, Raises Price Target to $225
Wells Fargo analyst Nathan Treybeck maintains iRhythm Technologies (NASDAQ:IRTC) with a Overweight and raises the price target from $220 to $225.
01-13 23:02
美股大行评级 | Medline获14家大行首予评级，最高目标价52美元；富国银行上调GOOGL目标价从268美元升至350美元
今日重点评级关注：HC Wainwright & Co.：维持Enlivex Therapeutics"买入"评级，目标价从7美元升至13美元；BTIG：维持Oruka Therapeutics"买入"评级，目标价从63美元升至73美元
01-13 10:18
iRhythm Technologies Sees FY2026 Sales $870.000M-$880.000M vs $862.682M Est
iRhythm Technologies (NASDAQ:IRTC) sees FY2026 sales of $870.000 million-$880.000 million vs $862.682 million analyst estimate.
01-12 20:42
iRhythm Technologies Raises FY2025 Sales Guidance from $735.000M-$740.000M to $740.000M vs $737.945M Est
iRhythm Technologies (NASDAQ:IRTC) raises FY2025 sales outlook from $735.000 million-$740.000 million to $740.000 million vs $737.945 million estimate.
01-12 20:42
美股大行评级 | 潜在涨幅36.7%！LMRI获多家大行首予超配评级； 瑞银下调甲骨文目标价从325美元至280美元
今日重点评级关注：HC Wainwright & Co.：维持Assertio Holdings"买入"评级，目标价从3美元升至35美元；HC Wainwright & Co.：维持万达生物制药"买入"评级，目标价从20美元升至22美元
01-06 17:52
Evercore ISI Group Upgrades iRhythm Technologies to Outperform, Raises Price Target to $210
Evercore ISI Group analyst Vijay Kumar upgrades iRhythm Technologies (NASDAQ:IRTC) from In-Line to Outperform and raises the price target from $194 to $210.
01-06 01:53
iRhythm Technologies to Present at the 44th Annual J.P. Morgan Healthcare Conference
iRhythm Technologies, Inc. will participate in the 44th Annual J.P. Morgan Healthcare Conference. Management will present on January 12, 2026, at 8:15 a.m. PT/11:15 a.m. ET. A live and archived webcast will be available on the company’s investor website. iRhythm, a digital health leader, focuses on trusted solutions to detect, predict, and prevent diseases using wearable biosensors and cloud-based analytics.
2025-12-29 21:30
Alphatec is the top performing healthcare equipment stock YTD
The S&P healthcare index (XLV) saw moderate gains in 2025, reaching a YTD increase of 12.2% by mid-December, though it fell short of its May highs. The sector is the sixth-highest performing sector a...
2025-12-23 01:12
